Product Recalls in New York

Product recalls affecting New York — including food, drugs, consumer products, medical devices, and vehicles distributed to New York. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 2,889 recalls have been distributed to New York in the last 12 months.

55,896 total recalls
2,889 in last 12 months

Showing 20812100 of 13,591 recalls

DrugMarch 15, 2023· Baxter Healthcare Corporation

Recalled Item: Dianeal Low Calcium (2.5 mEq/L) Peritonial Dialysis Solution with 1.5%...

The Issue: Lack of Assurance of Sterility: Potential presence of leaks originating from...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 14, 2023· Hetero USA Inc

Recalled Item: Pantoprazole Sodium Delayed Release Tablets USP 40mg Recalled by Hetero USA...

The Issue: CGMP Deviations: Discoloration

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 14, 2023· Ascend Laboratories, LLC

Recalled Item: Dabigatran Etexilate 150mg Capsules Recalled by Ascend Laboratories, LLC Due...

The Issue: CGMP Deviations: Detection of N-nitroso-dabigatran (NDAB) impurity levels...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 14, 2023· Ascend Laboratories, LLC

Recalled Item: Dabigatran Etexilate Capsules Recalled by Ascend Laboratories, LLC Due to...

The Issue: CGMP Deviations: Detection of N-nitroso-dabigatran (NDAB) impurity levels...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 13, 2023· Camber Pharmaceuticals Inc.

Recalled Item: Atovaquone Oral Suspension USP Recalled by Camber Pharmaceuticals Inc. Due...

The Issue: Microbial Contamination of Non-Sterile Product: Objectionable organism,...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugMarch 13, 2023· Direct Rx

Recalled Item: Simvastatin Recalled by Direct Rx Due to cGMP deviations

The Issue: cGMP deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 13, 2023· Direct Rx

Recalled Item: Glimepiride Recalled by Direct Rx Due to cGMP deviations

The Issue: cGMP deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 13, 2023· Direct Rx

Recalled Item: Simvastatin Recalled by Direct Rx Due to cGMP deviations

The Issue: cGMP deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 13, 2023· Direct Rx

Recalled Item: Ropinirole Recalled by Direct Rx Due to cGMP deviations

The Issue: cGMP deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 13, 2023· Direct Rx

Recalled Item: Glimepiride Recalled by Direct Rx Due to cGMP deviations

The Issue: cGMP deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 13, 2023· Direct Rx

Recalled Item: Glimepiride Recalled by Direct Rx Due to cGMP deviations

The Issue: cGMP deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 13, 2023· Direct Rx

Recalled Item: Ropinirole Recalled by Direct Rx Due to cGMP deviations

The Issue: cGMP deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 13, 2023· Direct Rx

Recalled Item: Simvastatin Recalled by Direct Rx Due to cGMP deviations

The Issue: cGMP deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 13, 2023· Direct Rx

Recalled Item: Finasteride Recalled by Direct Rx Due to cGMP deviations

The Issue: cGMP deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 13, 2023· Direct Rx

Recalled Item: Montelukast Sodium Tablets Recalled by Direct Rx Due to cGMP deviations

The Issue: cGMP deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 13, 2023· Direct Rx

Recalled Item: Simvastatin Recalled by Direct Rx Due to cGMP deviations

The Issue: cGMP deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 10, 2023· Noven Pharmaceuticals Inc

Recalled Item: Daytrana (methylphenidate transdermal system) CII Recalled by Noven...

The Issue: Defective Delivery System: Out of specification for shear.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 10, 2023· Noven Pharmaceuticals Inc

Recalled Item: Daytrana (methylphenidate transdermal system) CII Recalled by Noven...

The Issue: Defective Delivery System: Out of specification for shear.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 10, 2023· Noven Pharmaceuticals Inc

Recalled Item: Daytrana (methylphenidate transdermal system) CII Recalled by Noven...

The Issue: Defective Delivery System: Out of specification for shear.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 10, 2023· Noven Pharmaceuticals Inc

Recalled Item: Daytrana (methylphenidate transdermal system) CII Recalled by Noven...

The Issue: Defective Delivery System: Out of specification for shear.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund